Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV – a prospective observational cohort study

https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00226-8/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-9XDKeMN-484aoBsM6lCaiwKhIzHn-8kQvYsk_9ZtT9qGmLIA1e2xM_xnzjPLmDF4QJWlreNXDXQjD9duo6IGD0sB_jMw&utm_content=271743104&utm_source=hs_email